Comment on: TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013;36:1749-1757

Journal article

Open access

Peer reviewed

Diabetes care, Vol.36(12), pp.e223-E223

01/12/2013

Handle:

https://hdl.handle.net/10523/38351

Abstract

Diabetes Mellitus, Type 2 - drug therapy

Female

Humans

Hypoglycemic Agents - therapeutic use

Insulin Resistance - physiology

Insulin-Secreting Cells - physiology

Life Style

Male

Metformin - therapeutic use

Thiazoles - therapeutic use

url

https://doi.org/10.2337/dc13-1426View

Published (Version of record) Open

5 Record Views

Record Identifier: 9926530330101891
Title: Comment on: TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013;36:1749-1757
Creators: James C Baldi
Patrick J Manning
Paul L Hofman
Robert J Walker
Publication Details: Diabetes care, Vol.36(12), pp.e223-E223
Academic Unit: Medicine (DSM)
Date published ; e-published: 01/12/2013
Language: English
Resource Type ; Subtype: Journal article